D
etermining how cells distinguish between adaptive and maladaptive signals when they appear to share the same molecular pathways has been a vexing biological problem. The ability to identify distinctive features of a pathophysiological response compared with a physiological response would allow for the rational design of approaches to eliminate or diminish undesirable consequences of pathophysiological responses while preserving the beneficial effects of physiological signals. These issues are especially pertinent in the heart and in understanding the development of heart failure, for which Ͼ500,000 new cases are diagnosed in the United States each year. Major factors contributing to worsening heart failure include a number of compensatory neurohormonal signals intended to counteract decreased cardiac output, such as hyperadrenergic stimulation (1) . In a recent issue of PNAS, Balijepalli et al. (2) provide new insight into how adrenergic signaling pathways are organized in the heart.
Adrenergic signaling in the myocardium contributes to the control of heart rate (chronotropy), strength of contraction (inotropy), and rate of relaxation (lusitropy) by changing the levels of intracellular Ca 2ϩ or by altering the sensitivity of critical regulatory proteins to Ca 2ϩ . Signaling is mediated predominantly by two distinct ␤-adrenergic receptors, ␤ 1 and ␤ 2 , which differ in their abundance, distribution, and downstream signal transducers (3) . Approximately 75% of the cardiac ␤-adrenergic receptors are ␤ 1 , which appear to be distributed globally throughout the sarcolemma. ␤ 1 receptors couple to the G s heterotrimeric G protein. The lessabundant ␤ 2 receptors reside predominantly in caveolae (4), specialized compartments of the plasma membrane organized by caveolins. Caveolae are flask-shaped membrane invaginations rich in cholesterol and glycosphingolipids that house and coordinate multiple signaling components, many of which appear to be dedicated to Ca 2ϩ signaling (5) . Besides their distinct homes, ␤ 2 receptors also differ from ␤ 1 in that they couple to both G s and G i . Nevertheless, stimulation of either ␤ 1 or ␤ 2 activates adenylyl cyclase to increase intracellular cAMP. In turn, cAMP activates protein kinase A, resulting in the phosphorylation of key elements of the contractile apparatus and of proteins that control internal Ca 2ϩ levels. Prominent among the PKA targets are the L-type voltagegated Ca 2ϩ channels (Ca V 1.2), which open upon membrane depolarization, allowing Ca 2ϩ to enter the cell. The ''receptors'' for this Ca 2ϩ signal are the ryanodine receptors (RyR2), Ca 2ϩ release channels on the sarcoplasmic reticulum (SR) that flood the cytoplasm with additional Ca 2ϩ that then initiates contraction (Fig. 1) . PKA phosphorylation of L-type Ca 2ϩ channels potentiates inward Ca 2ϩ current and thereby augments contraction. Electrophysiological studies of L-type Ca 2ϩ current after adrenergic stimulation revealed important consequences of the localization and G protein-coupling differences between ␤ 1 and ␤ 2 receptor subtypes. By isolating L-type Ca 2ϩ channels within a patch pipette, Chen-Izu et al. (6) determined that remote stimulation (outside of the pipette) of ␤ 1 increased Ca 2ϩ channel current within the pipette, suggesting that ␤ 1 signaling included a diffusive second messenger. In contrast, ␤ 2 -specific agonists were effective only when included within the pipette. This membrane-delimited ␤ 2 signaling depended on G i , because inactivation of G i with pertussis toxin made ␤ 2 signaling diffusive. Several other studies have provided additional evidence for important functional consequences of differential signaling through the ␤-adrenergic receptors. For example, sustained signaling through ␤ 1 receptors led to myocyte apoptosis; this ␤ 1 -mediated proapoptotic signal depended on Ca 2ϩ influx through Ltype Ca 2ϩ channels and activation of Ca 2ϩ calmodulin-dependent kinase II (CaMKII) (7) . On the other hand, ␤ 2 activation was protective against apoptotic signals (8) (9) (10) . Like the membranedelimited activation of L-type Ca 2ϩ currents, coupling of ␤ 2 to G i was also necessary for prosurvival signaling; G i inactivation with pertussis toxin blocked protection (8 The ␤2 receptor and its accompanying Gi and Gs proteins are depicted within a caveola, organized by Cav-3. Localized L-type Ca 2ϩ channel potentiation in response to ␤2 agonists may contribute to Ca 2ϩ signaling cascades that are distinct from the larger Ca 2ϩ pool involved in excitation-contraction coupling. The ␤1 receptors, coupled solely to Gs, are depicted on the plasma membrane (PM) and outside of caveolae. Most L-type Ca 2ϩ channels are closely opposed to RyR in the SR. Influx of Ca 2ϩ through L-type Ca 2ϩ channels triggers opening of RyRs and release of Ca 2ϩ from the SR to activate the contractile machinery. (B) In heart failure, signaling through ␤2 receptors blunts ␤1 potentiation of L-type Ca 2ϩ channels through a Gidependent mechanism (19) . This blunted response may result from dysregulation of caveolar organization, thus disturbing the compartmentation of the ␤1 and ␤2 receptors.
channel pore-forming subunit, within caveolae in neonatal cardiac myocytes. Sucrose density gradients revealed the cosedimentation of ␣ 1C with caveolin-3 (Cav-3), the predominant caveolin isoform in the heart. As previously found, the ␤ 2 receptor was enriched in this fraction, and all of the important components of the ␤ 2 -adrenergic signaling complex (G s , G i , adenylyl cyclase, and PKA) were also present. Interestingly, disruption of caveolae with 10 mM methyl ␤-cyclodextrin (M␤CD) or inhibition of Cav-3 by small interfering RNA prevented ␤ 2 stimulation of L-type Ca 2ϩ channel current, suggesting that caveolar localization was necessary. Previously, it was known that Kv1.5 potassium channels are preferentially localized in caveolae (11) , and a fraction of cardiac Na ϩ channels cosediment with Cav-3 (12), although the functional consequences of the location of either ion channel within caveolae have not yet been determined.
The demonstration that ␤ 2 -mediated potentiation of L-type Ca 2ϩ currents was caveolae-dependent may have important consequences for the understanding and treatment of cardiac hypertrophy and heart failure. Approximately 90% of L-type Ca 2ϩ channels in adult cardiac myocytes are found within T tubules (13), a specialized architecture of tubular invaginations of the sarcolemma, where they face RyRs in the juxtaposed SR. This organization ensures instantaneous release of SR Ca 2ϩ stores throughout the cytoplasm after membrane depolarization. Although a small population of RyRs have been found in regions of the SR that are not associated with T tubules or the plasmalemma (14) , definitive demonstration and localization of ''orphan'' L-type Ca 2ϩ channels have been more elusive. The presence of L-type Ca 2ϩ channels not necessarily associated with the SR, as implied in this new study by Balijepalli et al. (2) , raises the possibility that Ca 2ϩ signaling through this subpopulation of channels may provide a specialized function different from excitation-contraction coupling, such as contributing to the signaling cascades that initiate cardiac hypertrophy. Although several lines of evidence have implicated Ca 2ϩ signaling in the development of hypertrophy, it has been difficult to understand how a myocyte can distinguish between hypertrophy-inducing signals and the much larger pool of internal Ca 2ϩ that rapidly rises and falls over a 10-fold concentration range with each heart beat (15) . A recent report suggests that the hypertrophic signal endothelin-1 increases nuclear Ca 2ϩ by an inositol 1,4,5-trisphosphate (IP 3 )-triggered release from IP 3 receptors in the nuclear membrane (16), the first convincing demonstration of a separable Ca 2ϩ signal in myocytes. Balijepalli et al. (2) present another example supporting the idea of cardiac Ca 2ϩ -signaling microdomains, this one being in the cytoplasm rather than the nucleus. The emerging picture here is that focal Ca 2ϩ changes, whether modest or large, at the site of Ca 2ϩ entry can signal downstream pathways, and that this signaling is restricted because of fast termination and rapid diffusion or extrusion, with little change in overall Ca 2ϩ concentration. Such a mechanism would allow for specific signaling despite the normal ''background'' Ca 2ϩ fluctuations that are a part of excitation-contraction coupling. It is interesting to speculate that protective adrenergic signaling through ␤ 2 receptors may be related to caveolar localization because CaMKII, necessary for the contrasting ␤ 1 -mediated apoptotic signal, has not been reported in caveolae.
The dependence on caveolar localization for ␤ 2 -mediated activation of L-type Ca 2ϩ channels and the role of both ␤ 2 and Ca 2ϩ signaling in cardiovascular physiology also place a new focus on caveolae and Cav-3 in particular. Could dysregulation of caveolar organization contribute to heart failure or cardiac hypertrophy by affecting this signaling complex? The development of heart failure in Cav-3 Ϫ/Ϫ mice (17) makes this an intriguing possibility and suggests that pharmacological modulation of caveolae may be a fruitful avenue for drug development. Further, in at least one report (18) , heart failure was accompanied by Cav-3 down-regulation. If destabilization or loss of caveolae contributed to heart failure such that ␤ 2 signaling was no longer segregated (Fig. 1) , it might provide a cogent explanation for the observation that adrenergic activation of L-type Ca 2ϩ currents in the failing heart is blunted because of ␤ 2 stimulation of a G i -dependent pathway (19) .
These observations also raise many new questions. For example, how is a subpopulation of L-type Ca 2ϩ channels targeted to caveolae? Because a postsynaptic density protein 95͞discs large͞ZO-1 (PDZ)-binding motif in the C terminus of ␤ 2 is important for receptor trafficking and coupling to G i (20) , it is interesting to consider that a PDZ motif in the C terminus of ␣ 1C , previously shown to be important for excitation-transcription coupling in neurons (21) , might provide the caveolar localization signal to L-type Ca 2ϩ channels. Also, certain key experiments in the Balijepalli et al. (2) study were performed in neonatal myocytes, which lack the elegant T tubule architecture important for excitation-contraction coupling in adult myocytes. It will be essential to determine whether caveolar localization of L-type Ca 2ϩ channels is critical for ␤ 2 -regulated L-type Ca 2ϩ currents in the adult and whether this arrangement is perturbed in heart failure. Regardless, this study by Balijepalli et al. (2) opens new possibilities for the modulation of pathophysiological signaling of the ␤-adrenergic system that may lead to novel therapies for heart failure. 
